Nir Messafi
@Deep Track Capital, Lp
Latest period2024 - Q3ReportedManaged Assets$3.153BTotal holdings69
Assets growth rate-5.9%Assets growth rate (2-Q avg)-4.96%Continuous growth in asset value0 quarters
Portfolio positions
This chart displays the top 10 holdings in Deep Track Capital, Lp's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 69 positions.
Assets under management
The assets under management (AUM) of Deep Track Capital, Lp over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 3.153B in assets, with a quarterly growth rate of -5.9% and a 2-quarter average growth rate of -4.96%. The portfolio is managed by Nir Messafi, and others.
Portfolio holdings
Investment | Portfolio % | Reported Value | Recent Activity |
---|---|---|---|
RGLSRegulus Therapeutics Inc
| 0.17% | $5.122M 3.263M shares@ $1.57 avg price | |
ALLKAllakos Inc
| 0.11% | $3.266M 5M shares@ $0.66 avg price | |
ANROAlto Neuroscience Inc
| 0.08% | $2.513M 219,648 shares@ $11.44 avg price | Decreased -57.07% |
PRTAProthena Corp Plc
| 0.08% | $2.342M 140,000 shares@ $16.73 avg price | New Position |
RLMDRelmada Therapeutics Inc
| 0.07% | $2.186M 674,833 shares@ $3.25 avg price | Decreased -45.34% |
ALGSAligos Therapeutics Inc
| 0.07% | $2.114M 244,110 shares@ $8.67 avg price | New Position |
SYRSSyros Pharmaceuticals Inc
| 0.06% | $1.781M 828,485 shares@ $2.16 avg price | |
MGXMetagenomi Inc
| 0.03% | $667,275 307,500 shares@ $2.17 avg price | Decreased -34.04% |
SRRKScholar Rock Hldg Corp
| 0.02% | $385,281 48,100 shares@ $8.01 avg price | Decreased -87.08% |